These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2891464)

  • 41. Stimulant medication and short attention span: a clinical approach.
    Davy T; Rodgers CL
    J Dev Behav Pediatr; 1989 Dec; 10(6):313-8. PubMed ID: 2513337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hyperkinetic disorders with attention deficit. Diagnostic and therapeutic approach].
    Vallée L; Pandit F
    Pediatrie; 1991; 46(11):719-29. PubMed ID: 1661401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using psychoactive medication to intervene in children's behaviour: an evidence-based practice?
    Parsonson BS
    J Prim Health Care; 2009 Mar; 1(1):6-10. PubMed ID: 20690480
    [No Abstract]   [Full Text] [Related]  

  • 44. The use of dopaminergic and stimulant drugs for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.
    Shenker A
    Adv Pediatr; 1992; 39():337-82. PubMed ID: 1359740
    [No Abstract]   [Full Text] [Related]  

  • 46. Attention-Deficit/Hyperactivity Disorder Across the Spectrum: From Childhood to Adulthood.
    Majarwitz DJ; Perumareddi P
    Prim Care; 2023 Mar; 50(1):21-36. PubMed ID: 36822725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bupropion treatment of attention-deficit hyperactivity disorder in adults.
    Wender PH; Reimherr FW
    Am J Psychiatry; 1990 Aug; 147(8):1018-20. PubMed ID: 2115746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Stimulant therapy of hyperkinetic syndrome in childhood and adolescence].
    Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr; 1990 Sep; 18(3):157-66. PubMed ID: 1981119
    [No Abstract]   [Full Text] [Related]  

  • 49. [Models of drug treatment in the attention deficit disorder with hyperactivity].
    Etchepareborda MC
    Rev Neurol; 2002 Feb; 34 Suppl 1():S98-S106. PubMed ID: 12447798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulants and the developing brain.
    Andersen SL
    Trends Pharmacol Sci; 2005 May; 26(5):237-43. PubMed ID: 15860370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity.
    Gualtieri CT; Hicks RE
    Psychiatr Clin North Am; 1985 Dec; 8(4):875-92. PubMed ID: 2867534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract]   [Full Text] [Related]  

  • 53. Stimulant medications in adults with attention deficit disorder.
    Gauthier M
    Can J Psychiatry; 1984 Aug; 29(5):435-40. PubMed ID: 6148139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An update on assessment and treatment of complex attention-deficit hyperactivity disorder.
    Hunt RD; Paguin A; Payton K
    Pediatr Ann; 2001 Mar; 30(3):162-72. PubMed ID: 11257946
    [No Abstract]   [Full Text] [Related]  

  • 55. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.
    Wilens TE; Biederman J; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):45-8. PubMed ID: 9000780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?
    Levy F; Hobbes G
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):802-5. PubMed ID: 2848797
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges.
    Mosheva M; Dar N; Rima Madi L; Weizman A; Gothelf D
    Int Clin Psychopharmacol; 2020 Nov; 35(6):300-304. PubMed ID: 32694317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidepressant drugs: additional clinical uses.
    Orsulak PJ; Waller D
    J Fam Pract; 1989 Feb; 28(2):209-16. PubMed ID: 2644393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of Adverse Effects of Psychotropic Medications.
    Romba C; Perez-Reisler M
    Pediatr Ann; 2020 Oct; 49(10):e431-e435. PubMed ID: 33034658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroleptic-induced tics in two hyperactive children.
    Gualtieri CT; Patterson DR
    Am J Psychiatry; 1986 Sep; 143(9):1176-7. PubMed ID: 2875666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.